Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 73

Sort by

Sort Order Select

Journal Articles

The Cost of Healthcare for Pediatric Patients with Sickle Cell Disease

Maite E. Houwing, MD, Frederick Thielen, Anne P.J. de Pagter, MD PhD, Jan A Hazelzet, MD PhD, Hedwig Blommestein, Carin A. Uyl-de Groot, Marjon H. Cnossen, MD PhD

Blood (2019) 134 (Supplement_1): 1030.

https://doi.org/10.1182/blood-2019-130372

Published: 2019

Journal Articles

Health Care Costs Associated with Contemporary Chronic Myelogenous Leukemia (CML) Therapy Compared to Other Hematologic Malignancies (HEM)

Jennifer J. Wilkes, MDMSCE, Gary H. Lyman, MD MPH, David R Doody, MS, Shasank R Chennupati, PharmD, MPH, Laura Becker, MS, Pamela E Morin, Lena E. Winestone, MD MSHP, Henry (Joe) Henk, PhD, Eric J Chow, MD MPH

Blood (2019) 134 (Supplement_1): 4753.

https://doi.org/10.1182/blood-2019-124106

Published: 2019

Journal Articles

Refining Blood Products Utilization: Every One (unit) Matters

Khaled Deeb, PhD MBA, MD, Chen Zhang, MD, Stanislav Ivanov, MD MPH, Eric Szu, MD, Louis Lit, MD

Blood (2019) 134 (Supplement_1): 4985.

https://doi.org/10.1182/blood-2019-121339

Published: 2019

Journal Articles

The Total Direct Cost of Healthcare in the United States in Patients with Sickle Cell Disease: A Propensity Score Matched Analysis

Jonathan Salcedo, MA, Colin M Young, PhD, Jenniffer Bulovic, MD MPH

Blood (2019) 134 (Supplement_1): 4671.

https://doi.org/10.1182/blood-2019-122597

Published: 2019

Journal Articles

Healthcare Costs in Patients with Cancer Increase with Increasing Risk of Venous Thromboembolism

Michael B. Streiff, MD, Keith R. McCrae, MD, Nicole M. Kuderer, MD, Dejan Milentijevic, PhD, Guillaume Germain, MA, François Laliberté, MA, Nguyen Le, BSc, Patrick Lefebvre, MA, Gary H. Lyman, MD MPH, FRCP, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 3799.

https://doi.org/10.1182/blood-2018-99-117121

Published: 2018

Journal Articles

Are We Doing Too Many HIT Tests III?

Syed Zia-ur-Rehman Shah, MD BPharm, Seshan Subramanian, MD

Blood (2018) 132 (Supplement 1): 2444.

https://doi.org/10.1182/blood-2018-99-110035

Published: 2018

Journal Articles

Increased Health Care Cost Associated with Venous Thromboembolism in Patients with Malignant Glioma

Heather Wright, DO, Chris E. Holmes, MD PhD, Alissa Thomas, MD

Blood (2018) 132 (Supplement 1): 3524.

https://doi.org/10.1182/blood-2018-99-120009

Published: 2018

Journal Articles

The Utility of Hereditary Thrombophilia Testing Among Hospitalized Patients: A Single Center Experience

Omar Abughanimeh, MD, Mohammad Tahboub, MD, Anahat Kaur, MD, Mouhanna Abu Ghanimeh, MD, Zhang Zhiheng, An-lin Cheng, PhD, Timothy Pluard, MD

Blood (2018) 132 (Supplement 1): 2231.

https://doi.org/10.1182/blood-2018-99-114082

Published: 2018

Journal Articles

Econsultation to Hematologists from Primary Care: An Assessment of Content and Patient Impact

Megan Leslie, BS, Sa Ra Park, MD, Jennifer Wang, MD, Kelly Mercer Davidson, MD, Kimberly Dowdell, MD

Blood (2018) 132 (Supplement 1): 2279.

https://doi.org/10.1182/blood-2018-99-114149

Published: 2018

Journal Articles

Recurrent Venous Thromboembolism (VTE), Major Bleeding (MB), and Associated Cost of Treatment with Low Molecular Weight Heparin (LMWH) or Direct Oral Anticoagulant (DOAC) in High Risk Patients with Gastrointestinal (GI) Malignancies: Retrospective Real-World Analysis at a Comprehensive Cancer Center

Alejandro Recio Boiles, MD, Ali McBride, PharmD,MS, Hani M. Babiker, MD, Nimer Alsaid, PhD MS, PharmD, Ivo Abraham, PhD RN, Emad Elquza, MD MBA

Blood (2018) 132 (Supplement 1): 5057.

https://doi.org/10.1182/blood-2018-99-114204

Published: 2018

Journal Articles

Health Care and out-of-Pocket (OOP) Costs Among Medicare Beneficiaries Diagnosed with Chronic Myeloid Leukemia (CML)

Kelly Kenzik, PhD, Ravi Bhatia, MD, Grant R Williams, Smita Bhatia, MD MPH

Blood (2018) 132 (Supplement 1): 4730.

https://doi.org/10.1182/blood-2018-99-110742

Published: 2018

Journal Articles

Inherited NUDT15 Variants Substantially Increased Infection and Related Medical Cost in Children with Acute Lymphoblastic Leukemia

Jiabi Qian, M.Sc, Chuang Jiang, PhD, Qian Wenji, PhD, Wenge Hao, MD, Jiayi WANG, MD, Yingyi He, MD& PhD, Hua Jiang, MD, Yin Ting Cheung, PhD, Hui Zhang, PhD

Blood (2018) 132 (Supplement 1): 320.

https://doi.org/10.1182/blood-2018-99-114400

Published: 2018

Journal Articles

Healthcare Costs in Elderly Patients with Acute Myeloid Leukemia (AML) in Routine Clinical Care in the United States (US)

Jill A Bell, PhD, Aaron Galaznik, MD, Sharanya Murty, PhD, Megan Pollack, PharmD, Augustina Ogbonnaya, MPH, Michael T. Eaddy, PharmD, PhD, Robert J. Fram, MD, Douglas V. Faller, MD PhD, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 3459.

https://doi.org/10.1182/blood.V130.Suppl_1.3459.3459

Published: 2017

Journal Articles

Economic Modeling of the Potential Impact of Chronic Myeloid Leukemia (CML) Monitoring on Healthcare Costs

Elias J. Jabbour, MD, Lisa Siegartel, MPH, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Dinara Makenbaeva, MD MBA

Blood (2017) 130 (Supplement 1): 3378.

https://doi.org/10.1182/blood.V130.Suppl_1.3378.3378

Published: 2017

Journal Articles

Economic Burden of Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) in the US

Abdalla Aly, PhD, Bela Bapat, MA, Saurabh Ray, PhD, Zhiyong Chen, PhD, Marc Botteman, MSc, MA

Blood (2017) 130 (Supplement 1): 3386.

https://doi.org/10.1182/blood.V130.Suppl_1.3386.3386

Published: 2017

Journal Articles

Direct Medical Care Costs Associated with β-Thalassemia Care in Italy

Emanuele Angelucci, Ali Antmen, MD, Stefano Losi, MA, Nigel Burrows, MA, Chris Bartiromo, X. Henry Hu, MD PhD

Blood (2017) 130 (Supplement 1): 3368.

https://doi.org/10.1182/blood.V130.Suppl_1.3368.3368

Published: 2017

Journal Articles

Trends in Mortality, Hospital Cost, and Length of Stay in Lung Cancer Patients with and without Iron Deficiency Anemia: Data from the Healthcare Cost and Utilization Project from 1999-2014

Stuthi Perimbeti, MD MPH, Kathleen Degen, MD, Kevin Ye Hou, MD, Erika Correa, MD MS, Praneeth Baratam, MD, Kristine Ward, MD, David Topolsky, MD, Maneesh Jain, MD, Pamela Ann Crilley, DO, Michael Styler, MD

Blood (2017) 130 (Supplement 1): 5578.

https://doi.org/10.1182/blood.V130.Suppl_1.5578.5578

Published: 2017

Journal Articles

Cost Offsets in the Treatment Journeys of Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Sikander Ailawadhi, Maral DerSarkissian, PhD, Mei Sheng Duh, MPH, ScD, Marie-Hélène Lafeuille, MA, George Posner, BA, Stephen Ralston, PhD, Erin Zagadailov, PharmD, MS, Abbie Ba-Mancini, MSc, MBA, Robert M Rifkin, MD

Blood (2017) 130 (Supplement 1): 5599.

https://doi.org/10.1182/blood.V130.Suppl_1.5599.5599

Published: 2017

Journal Articles

Direct Medical Care Cost Associated with β-Thalassemia Care in Turkey

Ali Antmen, MD, Emanuele Angelucci, Stefano Losi, MA, Nigel Burrows, MA, Chris Bartiromo, X. Henry Hu, MD PhD

Blood (2017) 130 (Supplement 1): 2094.

https://doi.org/10.1182/blood.V130.Suppl_1.2094.2094

Published: 2017

Journal Articles

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Bruce L. Davidson, MD MPH, Philip S. Wells, MD FRCPC, MSc, Martin H. Prins, MD PhD, Jan Beyer-Westendorf, MD, Anthonie WA. Lensing, MD PhD, Lloyd Haskell, MD, Bennett Levitan, MD PhD, François Laliberté, Veronica Ashton, MPH, Yongling Xiao, PhD, Dominique Lejeune, Concetta Crivera, Patrick Lefebvre, MA, Qi Zhao, MPH, Zhong Yuan, MD PhD, Jeff Schein, Paolo Prandoni, MD PhD

Blood (2017) 130 (Supplement 1): 218.

https://doi.org/10.1182/blood.V130.Suppl_1.218.218

Published: 2017

NARROW

The Cost of Healthcare for Pediatric Patients with Sickle Cell Disease

Health Care Costs Associated with Contemporary Chronic Myelogenous Leukemia (CML) Therapy Compared to Other Hematologic Malignancies (HEM)

Refining Blood Products Utilization: Every One (unit) Matters

The Total Direct Cost of Healthcare in the United States in Patients with Sickle Cell Disease: A Propensity Score Matched Analysis

Healthcare Costs in Patients with Cancer Increase with Increasing Risk of Venous Thromboembolism

Are We Doing Too Many HIT Tests III?

Increased Health Care Cost Associated with Venous Thromboembolism in Patients with Malignant Glioma

The Utility of Hereditary Thrombophilia Testing Among Hospitalized Patients: A Single Center Experience

Econsultation to Hematologists from Primary Care: An Assessment of Content and Patient Impact

Recurrent Venous Thromboembolism (VTE), Major Bleeding (MB), and Associated Cost of Treatment with Low Molecular Weight Heparin (LMWH) or Direct Oral Anticoagulant (DOAC) in High Risk Patients with Gastrointestinal (GI) Malignancies: Retrospective Real-World Analysis at a Comprehensive Cancer Center

Health Care and out-of-Pocket (OOP) Costs Among Medicare Beneficiaries Diagnosed with Chronic Myeloid Leukemia (CML)

Inherited NUDT15 Variants Substantially Increased Infection and Related Medical Cost in Children with Acute Lymphoblastic Leukemia

Healthcare Costs in Elderly Patients with Acute Myeloid Leukemia (AML) in Routine Clinical Care in the United States (US)

Economic Modeling of the Potential Impact of Chronic Myeloid Leukemia (CML) Monitoring on Healthcare Costs

Economic Burden of Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) in the US

Direct Medical Care Costs Associated with β-Thalassemia Care in Italy

Trends in Mortality, Hospital Cost, and Length of Stay in Lung Cancer Patients with and without Iron Deficiency Anemia: Data from the Healthcare Cost and Utilization Project from 1999-2014

Cost Offsets in the Treatment Journeys of Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Direct Medical Care Cost Associated with β-Thalassemia Care in Turkey

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only